Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$110M Hold
1,226,800
0.02% 981
2025
Q4
$114M Hold
1,226,800
0.02% 942
2025
Q3
$153M Hold
1,226,800
0.02% 736
2025
Q2
$161M Hold
1,226,800
0.03% 648
2025
Q1
$129M Hold
1,226,800
0.02% 766
2024
Q4
$133M Hold
1,226,800
0.02% 732
2024
Q3
$131M Hold
1,226,800
0.03% 600
2024
Q2
$121M Buy
+1,226,800
New +$123M 0.03% 547

Other funds holding ITRI

UBS Group's ITRI Position: Q1 2026 in Review

UBS Group increased its Itron (ITRI) stake by 7% in Q1 2026, buying an estimated $3.47M and bringing the position to 555,600 shares worth $49.8M. The position accounts for 0.01% of the portfolio, ranked #1646.

UBS Group first reported a position in ITRI in Q4 2014 and has held it in 46 quarters since. The position peaked at $67.7M in Q1 2025. 431 funds tracked by Wall St. Rank hold ITRI as of Q1 2026.

  • UBS Group held 555,600 shares of Itron worth $49.8M as of Q1 2026.
  • UBS Group bought 36,134 Itron shares in Q1 2026, an estimated $3.47M.
  • Itron made up 0.01% of UBS Group's portfolio in Q1 2026, its #1646 holding.
  • UBS Group first reported a position in Itron in Q4 2014 and has held it in 46 quarters since.
  • UBS Group's Itron position peaked at $67.7M in Q1 2025.
  • 431 funds tracked by Wall St. Rank held Itron as of Q1 2026.

Based on UBS Group's 13F filing for Q1 2026, filed 5 May 2026.